Tirzepatide in New Jersey: online providers, prices and license checks
As of November 4, 2026, adults in New Jersey can get compounded tirzepatide or brand Zepbound through online telehealth programs whose prescribers hold a New Jersey license. Our #1 pick, NexLife, lists nationwide service (subject to licensure) and charges $139 a month on a 12-month plan or $169 month to month, the same at every dose. Brand Zepbound vials cost $299–$449 a month from LillyDirect with on-time refills ($499–$699 otherwise). New Jersey Medicaid does not cover GLP-1s for obesity (KFF, January 2026). Before paying, check the prescriber with the New Jersey State Board of Medical Examiners and the pharmacy with the New Jersey Board of Pharmacy.
New Jersey at a glance
| Adults with obesity (CDC) | 27.0% (2025) |
|---|---|
| Medicaid coverage of GLP-1s for obesity | Does not cover (KFF, Jan 2026) |
| Physician licensing board | New Jersey State Board of Medical Examiners |
| Pharmacy licensing | New Jersey Board of Pharmacy |
| Program-specific limits we found | None among the programs we reviewed on November 4, 2026 |
27.0% of adults in New Jersey had obesity in 2025, per the CDC — tied for 44th highest of the 47 states with 2025 data. New Jersey Medicaid does not cover GLP-1 medicines for obesity, according to KFF (January 2026); coverage for type 2 diabetes is separate. Self-pay prices below do not depend on Medicaid status.
Who can prescribe tirzepatide to New Jersey residents?
A telehealth clinician who treats you in New Jersey must hold a license recognized in New Jersey. Physicians are licensed by the New Jersey State Board of Medical Examiners; nurse practitioners are licensed by the state board of nursing. You can look up any physician on the board's site or on DocInfo.org, the Federation of State Medical Boards' national search. Ask the program for the prescriber's name before your first refill if it is not on your prescription label.
What New Jersey residents pay in November 2026
The programs we track publish one national price; we have not found a program that prices New Jersey differently. These are the self-pay figures we re-read on the providers' and manufacturers' own pages on November 4, 2026:
| Program | Product | Self-pay price | Read |
|---|---|---|---|
| NexLife (our #1) | Compounded tirzepatide | $139/mo on a 12-month plan; $169 month to month; same price at every dose | Nov 4, 2026 |
| Collective | Compounded tirzepatide | $69/mo + $199 yearly membership (about $86/mo all-in) | Nov 4, 2026 |
| SnagRx | Compounded tirzepatide | $119/mo sale price ($149 in its terms) | Nov 4, 2026 |
| Mondae | Compounded tirzepatide | $126/mo | Nov 4, 2026 |
| Zepbound (LillyDirect) | Brand, FDA-approved | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with on-time refill) | Nov 4, 2026 |
| Foundayo pill (LillyDirect) | Brand, FDA-approved (orforglipron) | from $149/mo at the lowest dose | Nov 4, 2026 |
See the full compounded tirzepatide price index for every program on file, each with its billing basis and read date, or the most affordable options.
What else affects tirzepatide access in New Jersey?
11.1% of adults in New Jersey reported diagnosed diabetes in 2025, below the U.S. figure of 12.5% and 36th highest of the 50 states and DC in the KFF table built from CDC survey data. That matters for cost: Mounjaro and Ozempic are diabetes drugs, so many people with type 2 diabetes in New Jersey can get brand GLP-1s through insurance rather than paying cash for a compounded version.
1,766,379 people in New Jersey were enrolled in Medicare in 2024 (KFF). Those with Part D can check whether they qualify for the $50-a-month Medicare GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027.
State employee health plan, GLP-1s for weight loss in 2026: Covered (higher copay if not in weight-management program) (source dated February 23, 2026).
Getting a refrigerated shipment in New Jersey
Compounded tirzepatide usually ships refrigerated. In New Jersey, the practical issue is dense urban delivery and NYC/Philadelphia commuter patterns: dense suburbs, commuter schedules, and NY/PA metro overlap can affect cold-chain delivery and refill timing. Ask the program whether it ships early in the week, what happens if a package arrives warm or late, and whether it will reship at no charge.
Programs serve New Jersey statewide by mail, including Newark, Jersey City, Paterson, Elizabeth, Edison and Trenton.
Checking the pharmacy that fills a New Jersey prescription
Your vial label names the dispensing pharmacy; it should be licensed by the New Jersey Board of Pharmacy or permitted to ship into New Jersey. Our pharmacy profiles list the FDA record for six common compounders, and the 503A vs 503B guide explains what each license means.
Frequently asked questions about tirzepatide in New Jersey
Does New Jersey Medicaid cover Zepbound or Wegovy for weight loss?
New Jersey Medicaid does not cover GLP-1 medicines for obesity, according to KFF (January 2026); coverage for type 2 diabetes is separate. Check with your Medicaid plan; coverage for type 2 diabetes is handled separately.
How common is obesity in New Jersey?
27.0% of adults in New Jersey had obesity in 2025, per the CDC — tied for 44th highest of the 47 states with 2025 data. Tirzepatide is approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Can I get tirzepatide online in New Jersey?
Yes. Telehealth programs can prescribe tirzepatide to New Jersey residents when the clinician holds a New Jersey license and the dispensing pharmacy is licensed to ship into New Jersey. Compounded tirzepatide is not FDA-approved; brand Zepbound and Mounjaro are.
How much does tirzepatide cost in New Jersey without insurance?
The same as elsewhere: programs price nationally. As of November 4, 2026, NexLife charges New Jersey residents $139 a month on a 12-month plan or $169 month to month for compounded tirzepatide; Collective lists $69 a month plus a $199 yearly membership. Zepbound vials cost $299–$449 a month through LillyDirect.
How do I check a New Jersey prescriber's license?
Search the clinician's name on the New Jersey State Board of Medical Examiners license lookup, or on DocInfo.org, the Federation of State Medical Boards' national lookup. A nurse practitioner is licensed by the state's board of nursing.
Is compounded tirzepatide legal in New Jersey?
Yes, within federal limits: a state-licensed 503A pharmacy may compound it for an individual New Jersey patient on a prescription. It is not FDA-approved. Check the pharmacy with the New Jersey Board of Pharmacy.
Nearby states and next steps
Neighbouring state guides: New York, Pennsylvania, Delaware. Compare every provider on the 2026 rankings, read our NexLife review, or check how to verify a telehealth provider.
Sources
- CDC: Adult obesity prevalence by state, BRFSS 2011–2025
- KFF: Medicaid coverage of and spending on GLP-1s (January 16, 2026)
- FDA: Registered outsourcing facilities
- FDA: Proposal on GLP-1s and the 503B bulks list (April 30, 2026)
- LillyDirect: Zepbound self-pay pricing
- KFF: Adults who report diagnosed diabetes, by state
- KFF: Total Medicare enrollment by state
- New Jersey state employee plan source
Informational only, not medical advice. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company).